Search for: "Purdue Pharma LP"
Results 21 - 40
of 70
Sort by Relevance
|
Sort by Date
16 May 2018, 12:46 pm
Texas, Florida, Tennessee, North Carolina, North Dakota, Nevada and Pittsburgh [complaints, PDF] filed lawsuits on Tuesday against Purdue Pharma LP [corporate website] and other opioid painkiller makers, alleging the companies contributed to the current opioid crisis by misrepresenting the risks of their drugs. [read post]
21 Mar 2018, 10:57 am
Purdue Pharma LP (W.D. [read post]
21 Mar 2018, 4:41 am
Purdue Pharma LP (D.S.D.): Complaint [read post]
9 Jan 2018, 7:37 am
Purdue Pharma LP (D.S.D.): Complaint [read post]
3 Jan 2018, 7:13 am
Purdue Pharma LP, a Connecticut-based pharmaceutical manufacturer that produces drugs like OxyContin, is proposing a settlement for the various state lawsuits it has incurred over the national opioid crisis. [read post]
21 Jun 2017, 1:52 pm
Purdue Pharma LP, Johnson & Johnson and units of Endo International Plc. [read post]
22 May 2017, 5:49 am
Orange County, New York has filed a lawsuit against Purdue Pharma LP, Johnson & Johnson (JNJ, N) and other drug makers alleging they engaged in fraudulent marketing that played down the risks of prescription opioid painkillers leading the drug epidemic. [read post]
8 Feb 2017, 3:09 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
21 Nov 2016, 6:58 am
Purdue Pharma LP et al, 3-13-cv-00571 (NJD November 4, 2016, Order) (Bongiovanni, MJ) [read post]
14 Nov 2016, 9:16 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
23 Apr 2016, 2:58 pm
Companies including Purdue Pharma LP, Actavis PLC and Janssen Pharmaceuticals are asking the judgeThe post Drug Cos. [read post]
27 Mar 2016, 9:59 pm
Noonan -- Last Thursday, the Federal Circuit handed down its non-precedential decision in Purdue Pharma v. [read post]
6 Sep 2015, 8:26 am
" Purdue Pharma paid $600 million in fines, among the largest settlements in U.S. history for a pharmaceutical company.Three former and current executives of Purdue Pharma, LP, the maker of OxyContin, pled guilty to misdemeanor charges of drug misbranding on May 10, acknowledging that they deceived consumers about the risks associated with the drug. [read post]
29 Mar 2015, 9:59 pm
Purdue Pharma LP et al. v. [read post]
6 Mar 2015, 7:05 am
In a nearly 2,800-word piece, Bloomberg News (10/20, Armstrong, 1.94M) reports on the legal quagmire that Purdue Pharma LP finds itself in connection with its painkiller OxyContin (oxycodone). [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
15 Jul 2014, 7:10 am
Purdue Pharma LP et al, 3-13-cv-00571 (NJD July 9, 2014, Order) (Bongiovanni, M.J.) [read post]
